CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants of procedural success.

The TAVI-CLOSE study evaluated the efficacy and safety of two femoral access closure strategies after TAVI: closure with a dual suture device (dual Perclose ProGlide) vs a hybrid strategy consisting of a single suture plus a vascular plug (Perclose + Angio-Seal).

This was a prospective, randomized, single-center study conducted in the United States, in which patients were assigned in a 1:1 ratio to one of the two vascular closure strategies. Clinical follow-up extended to 30 days.

The primary endpoint (PE) was a composite of major access-site related bleeding and major vascular complications according to VARC-3 definitions. Secondary endpoints included minor vascular complications and total hospitalization costs.

The incidence of the primary endpoint was 2.1% in the dual suture group vs 7.1% in the suture + plug group. The absolute risk difference was 5% (95% CI −3.8% to 13.8%), exceeding the predefined non-inferiority margin.

Read also: CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon.

No serious events such as death, limb ischemia, embolization, or vascular perforation were reported. Procedural duration, fluoroscopy time, contrast volume, and length of hospital stay (approximately 1.1 days in both groups) were similar between strategies. Likewise, no differences were observed in total hospitalization costs, with a mean cost of approximately $42,000.

TAVI-CLOSE is the first randomized study conducted in the United States comparing vascular closure strategies after TAVI. The study demonstrated a low overall complication rate, with dual suture device closure emerging as the reference strategy.

Presented by Imran Baig at Late Breaking Clinical Trials, CRT 2026, Washington, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...